KEYNOTE-412: Phase 3 trial of pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. TPS6094-TPS6094
◽
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):